Content » Vol 96, Issue 3

Quiz

Giant Ulcer on Abdominal Wall: A Quiz

Giant Ulcer on Abdominal Wall: A Quiz

Hao Guo, Jiu-Hong Li*, Xiao-Yi Yang, Xiao-Lu Wang, Jie Cao, Song Zheng and Hong-Duo Chen

Department of Dermatology, No. 1 Hospital of China Medical University, 155N Nanjing Street, Shenyang 110001, China. E-mail: Pfkl2011@126.com

A 68-year-old Chinese male presented to our department with a large (20 × 40 cm), rapidly expanding, painful, necrotic skin ulcer that had developed on his lower abdomen 2 months previously (Fig. 1).The ulcer had started as pain and redness 3 days after a retro-pubic prostatectomy for benign prostatic hyperplasia at a local hospital. The patient was moderately feverish (38.5°C) and culture of the discharge revealed Staphylococcus aureus. However, there was no improvement in the patient’s condition after 2 weeks of treatment with Cefazolin 0.5 g twice daily.

 

4565fig1.tif
Fig. 1. Skin ulcer on the abdominal wall.

Laboratory tests revealed a white cell count of 11.23 × 109/l (normal range 3.5 × 109–9.5 × 109/l), haemoglobin 80 g/l (normal range 115–150 g/l), C-reactive protein 48 mg/l (normal range 0–10 mg/l) and erythrocyte sedimentation rate 45 mm/h (normal range 0–20 mm/h). All other tests were normal, including antinuclear antibodies, anti-neutrophil cytoplasmic antibodies, HIV, and Venereal Disease Research Laboratory test (VDRL) for syphilis.

What is your diagnosis? See next page for answer.

Giant Ulcer on Abdominal Wall: A Comment

Diagnosis: Post-surgical pyoderma gangrenosum (PSPG)

A skin biopsy specimen from the ulcer border revealed diffused infiltration of neutrophils, and fibrinoid necrosis of small vessels in the dermis and subcutaneous tissue peripheral to the base of the ulcer (Fig. 2a). Tissue culture for bacteria and fungus gave negative results.

The biopsy and tissue culture findings were consistent with pyoderma gangrenosum (PG).

Post-surgical PG (PSPG) is a specific condition with a series of characteristics in addition to the clinical features of PG (1). PSPG usually occurs in the first week following surgery (1); it may be acute and fulminant, and usually emerges with a painful and rapidly expanding ulcer. Fever, malaise, leukocytosis, and an elevated C-reactive protein may also be detected in PSPG (2–4). The lesions begin with a simple erythema around the sutures.

Differential diagnosis includes progressive synergistic gangrene, ecthyma gangrenosum, clostridial infection, atypical mycobacterial infection, systemic vasculitis, Sweet’s syndrome, granulomatous disorders and stasis ulceration (5). However, there are no specific clinical signatures that distinguish PSPG from other post-surgical infections (5).

The patient was treated with methylprednisolone (40 mg daily). After 2 weeks, the size of the ulcer had decreased and the pain was relieved. The ulcer was completely healed after 2 months of treatment, and cribriform scars were visible over the ulcer site (Fig. 2b). No recurrent disease was observed at 6-month follow-up.

There is currently no standard treatment for PSPG, but systemic prednisone is the most commonly used medication (6). In cases that do not respond to glucocorticoids alone, other agents may be used, either alone or combined with glucocorticoids. These agents include: cyclosporine, methotrexate, azathioprine, cyclophosphamide, infliximab, etanercept, adalimumab, alefacept, mycophenolate mofetil, dapsone, tacrolimus, chlorambucil, intravenous immunoglobulin, colchicine and interferon alpha (6, 7). Direct topical application of corticosteroids or immunomodulators to the ulcer maybe helpful (6). Surgical debridement or necrosectomy is contraindicated in PSPG (6, 7). Management of any active associated disease, such as ulcerative colitis, should also be considered.

4565fig2.tif

Fig. 2. (a) Ulceration with diffuse infiltration of neutrophils (haematoxylin-eosin staining, original magnification × 200). b) Completely healed ulcer 2 months after treatment.

ACKNOWLEDGEMENT

The authors would like to thank Dr He-Xiao Wang for language editing.

The authors declare no conflicts of interest.

REFERENCES

1. Ouazzani A, Berthe JV, de Fontaine S. Post-surgical pyoderma gangrenosum: a clinical entity. Acta Chir Belg 2007; 107: 424–428.

2. Sebastian VA, Carroll BT, Jessen ME. Pyoderma gangrenosum associated with chronic idiophthic myelofibrosis after artery bypss graft surgery. Interact Cardiovasc Thorac Surg 2010; 10: 135–137.

3. Noblett SE, Woodcock S. Port-site pyoderma gangrenosum – a rare complication of surgical trauma. Ann R Coll Surg Engl 2009; 91: 665–666.

4. Pekmezci S, Saribeyoglu K, Mat C. Pyoderma gangrenosum: an idiopathic case and recurrence after surgery. Surgery 1999; 126: 85–87.

5. Su WPD, Davis MDP, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004; 43: 790–800.

6. Dabade TS, Davis MD. Diagnosis and treatment of the neutrophilic dermatoses (pyoderma gangrenosum, Sweet’s syndrome). Dermatol Ther 2011; 24: 273–284.

7. Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, et al. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol 2015; 95: 525–531.